Media 31 Aug 2021 Orthocell’s (ASX:OCC) final patient completes treatment in tendon regeneration study Orthocell has been featured in The Market Herald, highlighting the follow-up announcement from our OrthoATI™ rotator cuff tendon regeneration study. Orthocell
Media, Video 03 Aug 2021 Video | Proactive Investors – Orthocell highlights potential for CelGro in treatment of lymphedema Orthocell CEO and Managing Director Paul Anderson speaks to Proactive after announcing a breakthrough tissue engineering study, combining CelGro™ with… Orthocell
Media 02 Aug 2021 Orthocell (ASX:OCC) has breakthrough tissue engineering study published in US Orthocell has been featured in The Market Herald, following the publication of our breakthrough tissue engineering study in the peer-reviewed… Orthocell
